CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

April 15, 2020

Primary Completion Date

April 15, 2024

Study Completion Date

April 15, 2026

Conditions

Cervical CancerChemotherapy

Interventions

DRUG

Tegafur, Gimeracil and Oteracil Potassium Capsules (one drug)

CCRT followed by Tegafur, Gimeracil and Oteracil Potassium Capsules consolidation chemotherapy

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER